Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Iranian naval commander Alireza Tangsiri killed in attack, says Israel- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- Flu activity in US could continue to rise for weeks, top CDC epidemiologist says
- Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust
- Invigorating Spots To Go Kayaking All over The Planet
- Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
- As Western heat wave ends, scientists try to make sense of its length and intensity
- Why is everyone talking about Paul Dano? George Clooney becomes the actor's latest defender in this 'time of cruelty.'
